Poster Sessions

Poster Hours

Sunday, November 10: 4:00 p.m.–7:30 p.m.
Monday, November 11: 7:30 a.m.–9:30 a.m. and 11:30 a.m.–4:30 p.m.
Tuesday, November 12: 7:30 a.m.–1:30 p.m.

Posters are in place at all times when Franklin Hall is open.

Poster Author Sessions

Authors will present their topic on Monday, November 11, 2013 in Franklin Hall from 7:30 a.m.–8:45 a.m. and 3:00 p.m.–4:00 p.m.

The following domestic and International posters will provide valuable research findings to treatment providers.

  • Short Message Service Interventions for the Substance Use Population
    MerriBeth Adams, PhD
  • Retention in OTP—What We Know
    Janet Aiyeku, MPA
  • From the Emergency Department (ED) through the OTP— Recent Findings on ED Visits and OTP Treatment involving Buprenorphine and Methadone
    Sara Azimi-Bolourian, PhD
  • Impact of Readiness-to-Change on Massage Therapy for Chronic Pain in Opioid Dependent Patients
    Victoria Asphaug, MScPH
  • Twelve Month Safety, Efficacy and Patient Satisfaction with an Implantable Formulation of Buprenorphine
    Genie Bailey, MD
  • Nutritional Status, Chronic Pain and Body Mass Index in ORT Patients
    Katharina Wiest, PhD
  • A Comprehensive Multistep Benzodiazepine Reduction Plan in a Suburban Opioid Treatment Program with Predominantly Prescribed Benzodiazepine Use
    Jonathan Berman, MD
  • Keys to Recovery—A Better Alternative to NA and AA
    Michael Alsep
  • Strategies for Integrating Psychosocial Treatment with Pharmacologic Management for Youth with Co-Occurring Opioid and Mental Health Disorders—The Therapeutic Health Services ENCOMPASS Experience
    Susan Caverly, PhD
  • Cocaine Use Reduction with Buprenorphine (CURB)—A Stimulant Abuse Clinical Trial in the OTP Setting
    Allan Cohen, MA
  • Benzodiazepine Use and Retention in Medication Assisted Treatment
    Jordan Deaner
  • Opioid Dependent College and University Students
    Peter DeMaria, MD
  • Gender-Specific Peer Support in a Comprehensive Women’s Treatment Program—Healing the Heart, the Mind and the Spirit of Women and their Children
    Darlene DeMore
  • Patient Self-Selection of IOP Level Services and Associated Outcomes
    Kathryn Floyd, MSW
  • Reducing Patient Attrition 5X5
    Arron Hightower, MA
  • The Impact of Stress and Trauma on Medication Assisted Treatment (MAT) and Initial Treatment Engagement (ITE) in Opioid Dependence Recovery
    Kellie Jaremko, BS
  • Extended-Release Naltrexone Treatment of Veterans with PTSD and other Co-Occurring Disorders—A Case Series
    Jessica Keyser, PhD
  • Integrated Care—One OTP’s Experience
    Evan Kletter, PhD
  • Specialty Care Medical Home—Improving Care to Vulnerable Elders on Methadone
    Michelle Kletter, BA
  • Finances and Budgets—The Part of Addictions We Don’t Treatment Plan For
    Dave Kneessy, MS
  • Co-Occurring Disorders and Higher Levels of Care at a Methadone Clinic
    Kathleen Lee, MA
  • Structured Entry vs. Unstructured Entry—Which Works Best?
    Deborah Malatesta, MSW
  • Relapse Prevention at ThanhDa Drug Treatment Center, Vietnam
    Minh Nguyen Phan
  • A Fee for Service Model in a Low Resource Country—Assessing Ability to Pay for the Cost of Methadone Treatment in the Absence of Insurance Coverage
    Thuy Nga Nguyen Thi, MS
  • Characteristics of Methadone Maintenance Treatment Patients Who Achieve Maximal Available Take-home Doses Privileges (two weeks)
    Einat Peles, PhD
  • Specially-trained Nurses Network Education Program for Hepatitis C Treatment in Outpatients—Results in 222 patients and benefits for drugs users with OST and inmates
    Andre Jean Remy, MD
  • Non-opioid Substance Use Among Opioid Dependent Patients Enrolling in Opioid Treatment Programs—A latent class analysis
    Andrew Rosenblum, PhD
  • Effective Collaboration within the Criminal Justice System
    Tracy Simmons-Hart, MS
  • Seeking Recovery in MAT—Observations from the MARS Project
    Jo Sotheran, PhD
  • Continuous Recovery Monitoring in the Treatment of Opioid Dependence
    Samuel Stein, FRCPsych
  • Subtle Neuro-Developmental Difficulties in Childhood and Opioid Misuse in Young Adulthood
    Samuel Stein, FRCPsych
  • Actual Causes of Death Among Patients Enrolled in Methadone Maintenance Treatment
    Jeanette Tetrault, MD
  • From START to Finish—Findings from the Starting Treatment with Agonist Replacement Therapies Study
    George Woody, MD
  • Analysis of the Impact of Treatment Persistence on Health Care Charges Among Opioid Dependent Patients Treated with Buprenorphine/Naloxone using a US Insurance Database
    Vladimir Zah, PhD(c)
  • Persistence and Healthcare Costs among US Medicaid Population Opioid Dependent Patients Treated with Buprenorphine/Naloxone Film and Tablet Formulations
    Vladimir Zah, PhD(c)
  • Changing Trends in Methadone Use and Abuse
    Jane C. Maxwell, PhD

Pin It on Pinterest

Share This